Search research articles
Contact Us
Filters
Showing results (741-750 of 757) with videos related to
Page
of 76
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist
Ian M Bell, Steven N Gallicchio, Michael R Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2021
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
Lihua E Budde, Sarit Assouline, Laurie H Sehn, et al.
Cancer Research
|
October 26, 2018
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel
Anne Monks, Yingdong Zhao, Curtis Hose, et al.
Journal of the American Chemical Society
|
July 25, 2024
Manipulating Ferroelectric Polarization and Spin Polarization of 2D CuInP<sub>2</sub>S<sub>6</sub> Crystals for Photocatalytic CO<sub>2</sub> Reduction
Chun-Hao Chiang, Cheng-Chieh Lin, Yin-Cheng Lin, et al.
Nanotechnology
|
July 3, 2024
Efficient photoanode with a MoS<sub>2</sub>/TiO<sub>2</sub>/Au nanoparticle heterostructure for ultraviolet-visible photoelectrocatalysis
The-Hung Mai, Huy-Binh Do, Long Duy Pham, et al.
Frontiers in Oncology
|
June 3, 2025
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models
Yvonne A Evrard, Sergio Y Alcoser, Michael Mullendore, et al.
Blood Advances
|
April 17, 2023
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Nancy L Bartlett, Sarit Assouline, Pratyush Giri, et al.
Clinical Lung Cancer
|
August 29, 2022
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Myung J Ahn, Hye R Kim, James C H Yang, et al.
JCO Precision Oncology
|
April 30, 2021
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial
Alice P Chen, Shivaani Kummar, Nancy Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 13, 2010
Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist
Christopher A Salvatore, Eric L Moore, Amy Calamari, et al.
Page
of 76
Search research articles
Search
Showing results (741-750 of 757) with videos related to
Sort By:
Page
of 76
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist
Ian M Bell, Steven N Gallicchio, Michael R Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2021
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
Lihua E Budde, Sarit Assouline, Laurie H Sehn, et al.
Cancer Research
|
October 26, 2018
The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel
Anne Monks, Yingdong Zhao, Curtis Hose, et al.
Journal of the American Chemical Society
|
July 25, 2024
Manipulating Ferroelectric Polarization and Spin Polarization of 2D CuInP<sub>2</sub>S<sub>6</sub> Crystals for Photocatalytic CO<sub>2</sub> Reduction
Chun-Hao Chiang, Cheng-Chieh Lin, Yin-Cheng Lin, et al.
Nanotechnology
|
July 3, 2024
Efficient photoanode with a MoS<sub>2</sub>/TiO<sub>2</sub>/Au nanoparticle heterostructure for ultraviolet-visible photoelectrocatalysis
The-Hung Mai, Huy-Binh Do, Long Duy Pham, et al.
Frontiers in Oncology
|
June 3, 2025
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models
Yvonne A Evrard, Sergio Y Alcoser, Michael Mullendore, et al.
Blood Advances
|
April 17, 2023
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Nancy L Bartlett, Sarit Assouline, Pratyush Giri, et al.
Clinical Lung Cancer
|
August 29, 2022
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Myung J Ahn, Hye R Kim, James C H Yang, et al.
JCO Precision Oncology
|
April 30, 2021
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial
Alice P Chen, Shivaani Kummar, Nancy Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 13, 2010
Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist
Christopher A Salvatore, Eric L Moore, Amy Calamari, et al.
Page
of 76